Abbott Laboratories

Health Care Equipment

ABT

$ 112 (0.41)%

Share price

$ 196 bn

Market Cap

$ 202 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.13x the weighted average for S&P 500

FY2021

Primary Climate Goal

Proj. YOY change in GHG emissions (Scope 1 + 2)

Weaker than the -6.6% weighted average for S&P 500

FY2022

Abbott Laboratories aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2018

This target has not been verified as science based according to SBTi

GHG emissions and Carbon intensity

Abbott Laboratories reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 930 Kt (+30/+3.3% y-o-y). At the sime time, carbon intensity was down at 26 t (-4.2 /-13.9% y-o-y).

No public disclosure of Scope 3 emissions has been found for Abbott Laboratories at the moment.

The company is committed to reducing Scope 1 + 2 by 30% by 2030 from a base year 2018, which translates into the estimated reduction of -27 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	930	533	397
2020Q4	900	498	402	34,608	26
2019Q4	962	540	422	31,904	30
2018Q4	980	535	445	30,578	32
2017Q4	1,018	540	478	27,390	37
2016Q4	1,120	527	592	20,853	54
2015Q4	1,114	507	607	20,405	55

Abbott Laboratories

Carbon footprint

Primary Climate Goal

Abbott Laboratories aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2018

GHG emissions and Carbon intensity

Abbott Laboratories's carbon footprint

Company environmental metrics